Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

A novel PET technique that visualizes spinal cord injuries provides critical information about which patients may be able to ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with spinocerebellar ataxia (SCA).

Spine injections should not be given to adults with chronic back pain because they provide little or no pain relief vs. sham ...

Pancreatic cancer can cause back pain that spreads from the abdomen ... larger section called the body a smaller part known as the tail Tumors that start to grow in the body and tail of the ...

As you might expect, this isn’t a cheap mattress. At full MSRP a queen size costs $3,399, a $100 increase for the new year. However, it’s usually discounted by as much as $600. Still, this is ...

Common reasons for back pain include muscle strain, disk damage, and some chronic conditions, such as fractures due to osteoporosis. Potential treatments include heat therapy, acupuncture ...

Anthony Albanese has warned alleged terror plotters they will face the “full might” of police after explosives and a note listing Jewish targets were found. A ...

The result of this literature review documents a remarkable list of various quantitative radiologic criteria applied to describe lumbar spinal stenosis. Measurement of antero-posterior diameter ...

Stryker (NYSE: SYK) + announced a deal to sell its U.S. spine implants business to investment firm Viscogliosi Brothers, which will call the new company VB Spine. Also after the market closed ...

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business ...

The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami (Fla.) Miller School of Medicine is the second U.S. site to join Neuralink's PRIME study, ...